SG55492G - Phenylacetic-acid derivatives,medicines containing these compounds and process for their preparation - Google Patents
Phenylacetic-acid derivatives,medicines containing these compounds and process for their preparationInfo
- Publication number
- SG55492G SG55492G SG554/92A SG55492A SG55492G SG 55492 G SG55492 G SG 55492G SG 554/92 A SG554/92 A SG 554/92A SG 55492 A SG55492 A SG 55492A SG 55492 G SG55492 G SG 55492G
- Authority
- SG
- Singapore
- Prior art keywords
- phenylacetic
- compounds
- preparation
- acid derivatives
- medicines containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/14—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Lubricants (AREA)
- Glass Compositions (AREA)
- Superconductors And Manufacturing Methods Therefor (AREA)
Abstract
1. Two new solid forms of 2-ethoxy-4-[N-(1-(2-piperidino- phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoic acid, the form designated (B) being characterised by the melting point of 140-142 degrees C and by the IR(KBr) spectrum according to Figure B' and the form designated (C) being characterised by a melting point of 75-85 degrees C and by the IR(KBr) spectrum according to Figure C'.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19833347565 DE3347565A1 (en) | 1983-12-30 | 1983-12-30 | NEW PHENYL ACETIC DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
| DE19853522604 DE3522604A1 (en) | 1983-12-30 | 1985-06-25 | NEW SOLID FORMS OF 2- (GAMMA) THOXY-4- (N- (1- (2- (2-PIPERIDINO-PHENYL) -3-METHYL-1-BUTYL) -AMINOCARBONYLMETHYL) -BENZOESIC ACID, MEDICINAL PRODUCTS CONTAINING THESE FORMS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG55492G true SG55492G (en) | 1992-10-02 |
Family
ID=37847099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG554/92A SG55492G (en) | 1983-12-30 | 1992-05-25 | Phenylacetic-acid derivatives,medicines containing these compounds and process for their preparation |
Country Status (26)
| Country | Link |
|---|---|
| EP (2) | EP0147850B1 (en) |
| JP (2) | JPH0623200B2 (en) |
| KR (1) | KR900005320B1 (en) |
| AT (1) | ATE44027T1 (en) |
| AU (2) | AU577815B2 (en) |
| BG (1) | BG61519B2 (en) |
| CA (2) | CA1225398A (en) |
| CS (1) | CS409791A3 (en) |
| DD (1) | DD231348A5 (en) |
| DE (4) | DE3347565A1 (en) |
| DK (2) | DK167439B1 (en) |
| ES (7) | ES8605500A1 (en) |
| FI (2) | FI80447C (en) |
| GR (2) | GR82614B (en) |
| HK (1) | HK87492A (en) |
| HU (1) | HU194548B (en) |
| IE (1) | IE57700B1 (en) |
| IL (2) | IL73963A (en) |
| LU (1) | LU90301I2 (en) |
| MX (1) | MX9202772A (en) |
| NL (1) | NL980034I1 (en) |
| NO (3) | NO162819C (en) |
| NZ (2) | NZ210657A (en) |
| PT (2) | PT79772B (en) |
| SG (1) | SG55492G (en) |
| ZA (2) | ZA8410103B (en) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3523466A1 (en) * | 1985-07-01 | 1987-01-08 | Thomae Gmbh Dr K | NEW PHENYL ACETIC DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
| DE3347565A1 (en) * | 1983-12-30 | 1985-07-11 | Thomae Gmbh Dr K | NEW PHENYL ACETIC DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
| ES2136600T3 (en) * | 1991-06-21 | 1999-12-01 | Boehringer Ingelheim Pharma | USE OF ACID (S) (+) - 2-ETOXI-4- (N- (1- (2-PIPERIDINO-FENIL) -3-METHYL-1-BUTYL) AMINO CARBONYL METHYL) -BENZOIC FOR THE PREPARATION OF A LONG ANTIDIABETIC DURATION. |
| WO1993000337A1 (en) * | 1991-06-21 | 1993-01-07 | Dr. Karl Thomae Gmbh | (s)(+)-2-ethoxy-4-[n-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid |
| FR2763590B1 (en) * | 1997-05-22 | 2000-03-24 | Synthelabo | ACID DERIVATIVES [[[(ARYLMETHYL) AMINO] CARBONYL] ALKYL] - AROMATICS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
| EP1741447B1 (en) | 2000-01-21 | 2013-09-18 | Novartis AG | Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| US20040102477A1 (en) * | 2002-08-23 | 2004-05-27 | Dr. Reddy's Laboratories Limited | Polymorphic forms of (S)-Repaglinide and the processes for preparation thereof |
| WO2004101540A2 (en) * | 2003-05-14 | 2004-11-25 | Cilag Ag | Method for the production of phenylacetic acid derivatives |
| AU2003237595A1 (en) * | 2003-05-26 | 2004-12-13 | Biocon Limited | Process for the preparation of s(+)-2-ethoxy-4-(n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl)benzoic acid derivatives |
| PE20050630A1 (en) * | 2003-06-09 | 2005-09-22 | Boehringer Ingelheim Int | HETEROCYCLIC COMPOUNDS AS PAPILLOMA VIRUS INHIBITORS |
| FR2875805B1 (en) * | 2004-09-27 | 2006-12-29 | Genfit S A | SUBSTITUTED N- (BENZYL) PHENYLACETAMIDE DERIVATIVE COMPOUNDS, PREPARATION AND USES |
| CN1305863C (en) * | 2004-12-27 | 2007-03-21 | 浙江大学 | Method for synthesizing (S)-isopropyl-(2-piperidine) phenyl-methylhistamine |
| GT200600381A (en) | 2005-08-25 | 2007-03-28 | ORGANIC COMPOUNDS | |
| HRP20140091T4 (en) | 2005-09-14 | 2021-12-24 | Takeda Pharmaceutical Company Limited | Administration of dipeptidyl peptidase inhibitors |
| EP2177221A1 (en) | 2008-10-20 | 2010-04-21 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process for the preparation of substantially optically pure Repaglinide and precursors thereof |
| WO2010130773A2 (en) | 2009-05-15 | 2010-11-18 | Novartis Ag | Benzoxazolone derivatives as aldosterone symthase inhibitors |
| JP5659224B2 (en) | 2009-05-15 | 2015-01-28 | ノバルティス アーゲー | Arylpyridines as aldosterone synthase inhibitors |
| KR20120041702A (en) | 2009-05-28 | 2012-05-02 | 노파르티스 아게 | Substituted aminobutyric derivatives as neprilysin inhibitors |
| AU2010251967B9 (en) | 2009-05-28 | 2014-04-03 | Novartis Ag | Substituted aminopropionic derivatives as neprilysin inhibitors |
| WO2011041293A1 (en) | 2009-09-30 | 2011-04-07 | Takeda Pharmaceutical Company Limited | Pyrazolo [1, 5-a] pyrimidine derivatives as apoptosis signal-regulating kinase 1 inhibitors |
| EP2501678B1 (en) | 2009-11-17 | 2015-09-23 | Novartis AG | Aryl-pyridine derivatives as aldosterone synthase inhibitors |
| JO2967B1 (en) | 2009-11-20 | 2016-03-15 | نوفارتس ايه جي | Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors |
| EP2507234B1 (en) | 2009-11-30 | 2014-03-12 | Novartis AG | Imidazole derivatives as aldosterone synthase inhibitors |
| CN102834393B (en) | 2010-02-03 | 2015-07-22 | 武田药品工业株式会社 | Apoptosis signal-regulating kinase 1 inhibitors |
| US8673974B2 (en) | 2010-11-16 | 2014-03-18 | Novartis Ag | Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors |
| US8877815B2 (en) | 2010-11-16 | 2014-11-04 | Novartis Ag | Substituted carbamoylcycloalkyl acetic acid derivatives as NEP |
| WO2012095548A2 (en) | 2011-01-13 | 2012-07-19 | Centro De Investigación Biomédica En Red De Enfermedades Neurodegenerativas (Ciberned) | Compounds for treating neurodegenerative disorders |
| UY35144A (en) | 2012-11-20 | 2014-06-30 | Novartis Ag | APELINE SYNTHETIC LINEAR MIMETICS FOR THE CARDIAC INSUFFICIENCY TREATMENT |
| CA2900027A1 (en) | 2013-02-14 | 2014-08-21 | Novartis Ag | Substituted bisphenyl butanoic phosphonic acid derivatives as nep (neutral endopeptidase) inhibitors |
| PE20160878A1 (en) | 2013-07-25 | 2016-09-08 | Novartis Ag | CYCLIC POLYPEPTIDES FOR THE TREATMENT OF HEART FAILURE |
| AU2014293387B2 (en) | 2013-07-25 | 2017-04-20 | Novartis Ag | Bioconjugates of synthetic apelin polypeptides |
| MX2017009534A (en) | 2015-01-23 | 2018-04-10 | Novartis Ag | Synthetic apelin fatty acid conjugates with improved half-life. |
| UY38072A (en) | 2018-02-07 | 2019-10-01 | Novartis Ag | COMPOSITIONS DERIVED FROM BUTANOIC ESTER SUBSTITUTED WITH BISPHENYL AS INHIBITORS OF NEP, COMPOSITIONS AND COMBINATIONS OF THE SAME |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3100575A1 (en) * | 1981-01-10 | 1982-09-02 | Dr. Karl Thomae Gmbh, 7950 Biberach | "NEW BENZOESAEURS, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS" |
| DE3100535A1 (en) * | 1981-01-10 | 1982-08-12 | Dr. Karl Thomae Gmbh, 7950 Biberach | "NEW CARBONIC ACID DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS" |
| SU1170969A3 (en) * | 1982-07-06 | 1985-07-30 | Др.Карл Томэ,Гмбх (Фирма) | Method of producing derivatives of phenylacetic acid or their salts |
| FR2554875B1 (en) * | 1983-11-10 | 1986-02-28 | Dba | HYDRAULIC BRAKE AMPLIFIER |
| DE3347565A1 (en) * | 1983-12-30 | 1985-07-11 | Thomae Gmbh Dr K | NEW PHENYL ACETIC DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
| DE3523466A1 (en) * | 1985-07-01 | 1987-01-08 | Thomae Gmbh Dr K | NEW PHENYL ACETIC DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF |
-
1983
- 1983-12-30 DE DE19833347565 patent/DE3347565A1/en not_active Withdrawn
-
1984
- 1984-12-20 DK DK613184A patent/DK167439B1/en active Protection Beyond IP Right Term
- 1984-12-20 NZ NZ210657A patent/NZ210657A/en unknown
- 1984-12-24 JP JP59272685A patent/JPH0623200B2/en not_active Expired - Lifetime
- 1984-12-27 DE DE8484116359T patent/DE3478682D1/en not_active Expired
- 1984-12-27 EP EP84116359A patent/EP0147850B1/en not_active Expired
- 1984-12-27 DE DE1998175044 patent/DE19875044I2/en active Active
- 1984-12-27 ES ES539078A patent/ES8605500A1/en not_active Expired
- 1984-12-27 AT AT84116359T patent/ATE44027T1/en active
- 1984-12-28 IE IE3349/84A patent/IE57700B1/en not_active IP Right Cessation
- 1984-12-28 DD DD84272061A patent/DD231348A5/en not_active IP Right Cessation
- 1984-12-28 ZA ZA8410103A patent/ZA8410103B/en unknown
- 1984-12-28 FI FI845145A patent/FI80447C/en active IP Right Grant
- 1984-12-28 CA CA000471120A patent/CA1225398A/en not_active Expired
- 1984-12-28 HU HU844870A patent/HU194548B/en unknown
- 1984-12-28 GR GR82614A patent/GR82614B/en unknown
- 1984-12-28 IL IL73963A patent/IL73963A/en not_active IP Right Cessation
- 1984-12-28 AU AU37210/84A patent/AU577815B2/en not_active Expired
- 1984-12-28 NO NO845282A patent/NO162819C/en not_active IP Right Cessation
- 1984-12-28 KR KR1019840008504A patent/KR900005320B1/en not_active IP Right Cessation
- 1984-12-28 PT PT79772A patent/PT79772B/en unknown
-
1985
- 1985-06-25 DE DE19853522604 patent/DE3522604A1/en not_active Withdrawn
- 1985-08-05 ES ES545882A patent/ES8604547A1/en not_active Expired
- 1985-08-05 ES ES545880A patent/ES8604545A1/en not_active Expired
- 1985-08-05 ES ES545881A patent/ES8604546A1/en not_active Expired
- 1985-08-05 ES ES545883A patent/ES8604548A1/en not_active Expired
- 1985-08-05 ES ES545879A patent/ES8604544A1/en not_active Expired
-
1986
- 1986-06-10 EP EP86107890A patent/EP0207331B1/en not_active Expired - Lifetime
- 1986-06-16 GR GR861558A patent/GR861558B/en unknown
- 1986-06-23 FI FI862650A patent/FI82689C/en not_active IP Right Cessation
- 1986-06-24 ES ES556495A patent/ES8802145A1/en not_active Expired
- 1986-06-24 IL IL79217A patent/IL79217A/en not_active IP Right Cessation
- 1986-06-24 AU AU59139/86A patent/AU583631B2/en not_active Expired
- 1986-06-24 JP JP61148027A patent/JPH0739405B2/en not_active Expired - Lifetime
- 1986-06-24 PT PT82832A patent/PT82832B/en unknown
- 1986-06-24 ZA ZA864695A patent/ZA864695B/en unknown
- 1986-06-24 NO NO862532A patent/NO168302C/en not_active IP Right Cessation
- 1986-06-24 NZ NZ216640A patent/NZ216640A/en unknown
- 1986-06-24 DK DK296686A patent/DK167573B1/en not_active IP Right Cessation
- 1986-06-24 CA CA000512269A patent/CA1292000C/en not_active Expired - Lifetime
-
1991
- 1991-12-27 CS CS914097A patent/CS409791A3/en unknown
-
1992
- 1992-05-25 SG SG554/92A patent/SG55492G/en unknown
- 1992-06-10 MX MX9202772A patent/MX9202772A/en unknown
- 1992-11-05 HK HK874/92A patent/HK87492A/en not_active IP Right Cessation
-
1994
- 1994-01-24 BG BG098407A patent/BG61519B2/en unknown
-
1998
- 1998-10-21 LU LU90301C patent/LU90301I2/en unknown
- 1998-11-18 NL NL980034C patent/NL980034I1/en unknown
-
1999
- 1999-07-20 NO NO1999016C patent/NO1999016I1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3478682D1 (en) | Phenylacetic-acid derivatives, medicines containing these compounds and process for their preparation |